Testing effectiveness (Phase 2)Study completedNCT00947427
What this trial is testing
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
Who this might be right for
Type 1 DiabetesPreservation of Insulin SecretionNewly Diagnosed Type 1 Diabetes+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 71